Table of Contents Author Guidelines Submit a Manuscript
International Journal of Surgical Oncology
Volume 2012, Article ID 406568, 12 pages
http://dx.doi.org/10.1155/2012/406568
Research Article

Clinicopathologic Comparison of High-Dose-Rate Endorectal Brachytherapy versus Conventional Chemoradiotherapy in the Neoadjuvant Setting for Resectable Stages II and III Low Rectal Cancer

1Department of Radiation Oncology & Molecular Radiation Sciences, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD 21205-2196, USA
2Department of Pathology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD 21205-2196, USA
3Department of Radiology, Johns Hopkins University School of Medicine, Baltimore, MD 21205-2196, USA
4Department of Surgery, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD 21205-2196, USA
5Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD 21205-2196, USA

Received 16 April 2012; Accepted 15 May 2012

Academic Editor: Nikolaos Touroutoglou

Copyright © 2012 Jessica A. Smith et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. W. M. Mendenhall, R. A. Zlotecki, F. E. Snead et al., “Radiotherapy in the treatment of resectable rectal adenocarcinoma,” American Journal of Clinical Oncology, vol. 32, no. 6, pp. 629–638, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. R. Siegel, D. Naishadham, and A. Jemal, “Cancer statistics, 2012,” Cancer Journal for Clinicians, vol. 62, no. 1, pp. 10–29, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. J. Meyer, G. Balch, C. Willett, and B. Czito, “Update on treatment advances in combined-modality therapy for anal and rectal carcinomas,” Current Oncology Reports, vol. 13, no. 3, pp. 177–185, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. T. Vuong, S. Devic, and E. Podgorsak, “High dose rate endorectal brachytherapy as a neoadjuvant treatment for patients with resectable rectal cancer,” Clinical Oncology, vol. 19, no. 9, pp. 701–705, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. R. Martínez-Monge, A. Gómez-Iturriaga, M. Cambeiro et al., “Phase I-II trial of perioperative high-dose-rate brachytherapy in oral cavity and oropharyngeal cancer,” Brachytherapy, vol. 8, no. 1, pp. 26–33, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. T. Vuong, P. Szego, M. David et al., “The safety and usefulness of high-dose-rate endoluminal brachytherapy as a boost in the treatment of patients with esophageal cancer with external beam radiation with or without chemotherapy,” International Journal of Radiation Oncology Biology Physics, vol. 63, no. 3, pp. 758–764, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. W. Harms, H. D. Becker, R. Krempien, and M. Wannenmacher, “Contemporary role of modern brachytherapy techniques in the management of malignant thoracic tumors,” Seminars in Surgical Oncology, vol. 20, no. 1, pp. 57–65, 2001. View at Publisher · View at Google Scholar · View at Scopus
  8. T. Vuong, P. J. Belliveau, R. P. Michel et al., “Conformal preoperative endorectal brachytherapy treatment for locally advanced rectal cancer: early results of a phase I/II study,” Diseases of the Colon and Rectum, vol. 45, no. 11, pp. 1486–1495, 2002. View at Publisher · View at Google Scholar · View at Scopus
  9. R. Sauer, H. Becker, W. Hohenberger et al., “Preoperative versus postoperative chemoradiotherapy for rectal cancer,” The New England Journal of Medicine, vol. 351, no. 17, pp. 1731–1740, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. C. Rödel, P. Martus, T. Papadoupolos et al., “Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer,” Journal of Clinical Oncology, vol. 23, no. 34, pp. 8688–8696, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. R. Glynne-Jones, D. Sebag-Montefiore, T. S. Maughan, S. J. Falk, and A. C. McDonald, “A phase I dose escalation study of continuous oral capecitabine in combination with oxaliplatin and pelvic radiation (XELOX-RT) in patients with locally advanced rectal cancer,” Annals of Oncology, vol. 17, no. 1, pp. 50–56, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. J. P. Machiels, L. Duck, B. Honhon et al., “Phase II study of preoperative oxaliplatin, capecitabine and external beam radiotherapy in patients with rectal cancer: the RadiOxCape study,” Annals of Oncology, vol. 16, no. 12, pp. 1898–1905, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. H. Rutten, D. Sebag Montefiore, R. Glynne-Jones et al., “Capecitabine, oxaliplatin, radiotherapy, and excision (CORE) in patients with MRI-defined locally advanced rectal adenocarcinoma: results of an international multicenter phase II study,” Journal of Clinical Oncology, vol. 24, no. 18S, supplement, 2006. View at Google Scholar
  14. J. P. Gérard, T. Conroy, F. Bonnetain et al., “Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203,” Journal of Clinical Oncology, vol. 24, no. 28, pp. 4620–4625, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. J. P. Gerard, F. Bonnetain, and T. Conroy, “Preoperative (perop) radiotherapy (RT) (+/−) 5 FU/folinic acid (FA) in T3-4 rectal cancers: results of the FFCD 9203 randomized trial,” Journal of Clinical Oncology, vol. 23, no. 247s, supplement, 2005. View at Google Scholar
  16. R. Fietkau, M. Barten, G. Klautke et al., “Postoperative chemotherapy may not be necessary for patients with ypN0-category after neoadjuvant chemoradiotherapy of rectal cancer,” Diseases of the Colon and Rectum, vol. 49, no. 9, pp. 1284–1292, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Maas, P. J. Nelemans, V. Valentini et al., “Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data,” The Lancet Oncology, vol. 11, no. 9, pp. 835–844, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. F. Stipa, D. B. Chessin, J. Shia et al., “A pathologic complete response of rectal cancer to preoperative combined-modality therapy results in improved oncological outcome compared with those who achieve no downstaging on the basis of preoperative endorectal ultrasonography,” Annals of Surgical Oncology, vol. 13, no. 8, pp. 1047–1053, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. C. Capirci, V. Valentini, L. Cionini et al., “Prognostic value of pathologic complete response after neoadjuvant therapy in locally advanced rectal cancer: long-term analysis of 566 ypCR patients,” International Journal of Radiation Oncology Biology Physics, vol. 72, no. 1, pp. 99–107, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. L. F. de Campos-Lobato, L. Stocchi, A. da Luz Moreira et al., “Pathologic complete response after neoadjuvant treatment for rectal cancer decreases distant recurrence and could eradicate local recurrence,” Annals of Surgical Oncology, vol. 18, no. 6, pp. 1590–1598, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. A. M. Wolthuis, F. Penninckx, K. Haustermans, N. Ectors, E. Van Cutsem, and A. D'Hoore, “Outcome standards for an organ preservation strategy in stage II and III rectal adenocarcinoma after neoadjuvant chemoradiation,” Annals of Surgical Oncology, vol. 18, no. 3, pp. 684–690, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. C. Belluco, A. De Paoli, V. Canzonieri et al., “Long-term outcome of patients with complete pathologic response after neoadjuvant chemoradiation for cT3 rectal cancer: implications for local excision surgical strategies,” Annals of Surgical Oncology, vol. 18, no. 13, pp. 3686–3693, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. E. Kapiteijn, C. A. M. Marijnen, I. D. Nagtegaal et al., “Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer,” The New England Journal of Medicine, vol. 345, no. 9, pp. 638–646, 2001. View at Publisher · View at Google Scholar · View at Scopus
  24. E. Kapiteijn and C. J. H. van De Velde, “European trials with total mesorectal excision,” Seminars in Surgical Oncology, vol. 19, no. 4, pp. 350–357, 2000. View at Publisher · View at Google Scholar · View at Scopus
  25. L. Arbea, L. I. Ramos, R. Martínez-Monge, M. Moreno, and J. Aristu, “Intensity-modulated radiation therapy (IMRT) vs. 3D conformal radiotherapy (3DCRT) in locally advanced rectal cancer (LARC): dosimetric comparison and clinical implications,” Radiation Oncology, vol. 5, no. 1, article 17, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. G. Branagan, H. Chave, C. Fuller, S. McGee, and D. Finnis, “Can magnetic resonance imaging predict circumferential margins and TNM stage in rectal cancer?” Diseases of the Colon and Rectum, vol. 47, no. 8, pp. 1317–1322, 2004. View at Publisher · View at Google Scholar · View at Scopus
  27. S. K. Chennupati, A. Quon, A. Kamaya et al., “Positron emission tomography for predicting pathologic response after neoadjuvant chemoradiotherapy for locally advanced rectal cancer,” American Journal of Clinical Oncology, 2011. In press. View at Publisher · View at Google Scholar
  28. C. M. Fenoglio-Preiser, A. Noffsing, G. Stennernan, P. Lantz, and P. G. Isaacson, “Epithelial neoplasms of the colon,” in Gastrointestinal Pathology: An Atlas and Text, pp. 796–800, Lippincott, Williams, & Wilkins, Philadelphia, Pa, USA, 3rd edition, 2008. View at Google Scholar
  29. M. Hauer-Jensen, “Late radiation injury of the small intestine. Clinical, pathophysiologic and radiobiologic aspects. A review,” Acta Oncologica, vol. 29, no. 4, pp. 401–415, 1990. View at Google Scholar · View at Scopus
  30. C. W. Langberg and M. Hauer-Jensen, “Influence of fraction size on the development of late radiation enteropathy: an experimental study in the rat,” Acta Oncologica, vol. 35, no. 1, pp. 89–94, 1996. View at Google Scholar · View at Scopus
  31. A. Shapiro, O. Shapiro, N. B. Delongchamps, J. A. Bogart, G. P. Haas, and G. De La Rosa, “Autopsy evaluation of a prostate cancer case treated with brachytherapy,” Anticancer Research, vol. 28, no. 6, pp. 3909–3912, 2008. View at Google Scholar · View at Scopus
  32. T. Akasu, H. Kondo, Y. Moriya et al., “Endorectal ultrasonography and treatment of early stage rectal cancer,” World Journal of Surgery, vol. 24, no. 9, pp. 1061–1068, 2000. View at Google Scholar · View at Scopus
  33. S. Bipat, A. S. Glas, F. J. M. Slors, A. H. Zwinderman, P. M. M. Bossuyt, and J. Stoker, “Rectal cancer: local staging and assessment of lymph node involvement with endoluminal US, CT, and MR imaging—a meta-analysis,” Radiology, vol. 232, no. 3, pp. 773–783, 2004. View at Publisher · View at Google Scholar · View at Scopus
  34. F. Marusch, H. Lippert, A. Koch et al., “Routine use of transrectal ultrasound in rectal carcinoma: results of a prospective multicenter study,” Endoscopy, vol. 34, no. 5, pp. 385–390, 2002. View at Publisher · View at Google Scholar · View at Scopus
  35. H. Ptok, F. Marusch, F. Meyer et al., “Feasibility and accuracy of TRUS in the pre-treatment staging for rectal carcinoma in general practice,” European Journal of Surgical Oncology, vol. 32, no. 4, pp. 420–425, 2006. View at Publisher · View at Google Scholar · View at Scopus